Related Experiment Video
Updated: Aug 6, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
HOXC11 promotes head and neck squamous cell carcinomas (HNSCC) progression by regulating SPHK1 through the Wnt
Jing Zhang1,2,3, Qionghui Wu1,2,3, Jingyuan Liu1,2,3
1Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Abstract:
The discovery of potential targets in Head and neck squamous cell carcinomas (HNSCC) through molecular and mechanism analyses is crucial for understanding and treating this disease. This study utilized rigorous methods, including cell lines (FaDu and SCC-15) and a xenograft tumor model. Transfections were conducted using the Lipofectamine 2000 kit, and the evaluation of HOXC11, SPHK1, apoptosis-related protein, and the Wnt signaling pathway was carried out using qPCR and WB methods. The cell proliferation, migration, invasion, and apoptosis were comprehensively evaluated using colony formation, Transwell, wound healing, and flow cytometry, respectively. HOXC11 and SPHK1 are highly expressed in HNSCC and might be involved in the Wnt signaling pathway. HOXC11 promoted cell proliferation, migration, and invasion, inhibiting apoptosis in HNSCC. Silencing SPHK1 inhibited cell progression and dysregulated the Wnt signaling pathway in HNSCC. Overexpressed SPHK1 reversed the functions of sh-HOXC11 in regulating cell progression and the Wnt signaling pathway. HOXC11 promotes HNSCC progression by regulating SPHK1 through the Wnt signaling pathway. Silencing HOXC11 inhibited the tumor growth of HNSCC. Our study demonstrates that HOXC11 promotes HNSCC progression by regulating SPHK1 through the Wnt/β-catenin signaling pathway, identifying a previously unrecognized regulatory axis in HNSCC.
Insights
HOXC11 promotes head and neck squamous cell carcinoma (HNSCC) progression by regulating SPHK1 via the Wnt/β-catenin pathway. Silencing HOXC11 inhibits HNSCC tumor growth, revealing a new therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling
Background:
- Head and neck squamous cell carcinomas (HNSCC) require novel therapeutic targets.
- Understanding molecular mechanisms driving HNSCC progression is critical.
Purpose of the Study:
- To investigate the roles of HOXC11 and SPHK1 in HNSCC.
- To elucidate the involvement of the Wnt signaling pathway in HNSCC pathogenesis.
- To identify a novel regulatory axis in HNSCC.
Main Methods:
- Utilized HNSCC cell lines (FaDu, SCC-15) and a xenograft model.
- Employed quantitative PCR (qPCR) and Western Blotting (WB) for gene and protein analysis.
- Assessed cell proliferation, migration, invasion, and apoptosis using colony formation, Transwell assays, wound healing, and flow cytometry.
Main Results:
- HOXC11 and SPHK1 were highly expressed in HNSCC and linked to the Wnt pathway.
- HOXC11 promoted proliferation, migration, invasion, and inhibited apoptosis in HNSCC.
- SPHK1 silencing impaired HNSCC progression and altered Wnt signaling; its overexpression reversed HOXC11 knockdown effects.
- HOXC11 promotes HNSCC progression by upregulating SPHK1 via the Wnt/β-catenin pathway.
Conclusions:
- HOXC11 drives HNSCC progression through the HOXC11/SPHK1/Wnt/β-catenin axis.
- Targeting HOXC11 presents a potential therapeutic strategy for HNSCC.
- This study identifies a novel regulatory mechanism in HNSCC development.
Related Concept Videos
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Abnormal Proliferation
